☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
App
Advertisement
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Aldeyra Therapeutics Reports the US FDA Acceptance of NDA for Priority Review of ADX-2191 for the Treatment of Primary Vitreoretin...
March 3, 2023
PharmaShots Weekly Snapshots (February 27 – March 03, 2023)
March 3, 2023
Flamingo Therapeutics Signed a Definitive Merger Agreement with Dynacure to Advance RNA-Targeted Oncology Therapies
March 3, 2023
Neuro20 Technologies Receives the US FDA Clearance of Neuro20 PRO System for Treatment of Neuromuscular Injury and Disease
March 3, 2023
Santhera Reports the MAA Submission to the MHRA for Vamorolone to Treat Duchenne Muscular Dystrophy
March 3, 2023
Avenue Therapeutics Entered into an Exclusive License Agreement with AnnJi to Develop and Commercialize AJ201 for Spinal and Bulba...
March 3, 2023
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions